Clinical variables and ethnicity may influenced by polymorphism of CAT −262C/T and MnSOD 47C/T antioxidant enzymes in Algerian type1 diabetes without complications-Reference-Cited by-同舟云学术

Clinical variables and ethnicity may influenced by polymorphism of CAT −262C/T and MnSOD 47C/T antioxidant enzymes in Algerian type1 diabetes without complications

Published:2018-09 Issue: Volume:670 Page:182-192
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Eddaikra A.^ORCID,Amroun H.,Raache R.,Galleze A.,Abdallah-Elhadj N.,Azzouz M.,Meçabih F.,Mechti B.,Abbadi M.C.,Touil-Boukoffa C.,Attal N.

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference92 articles.

1. Associations between catalase phenotype and genotype: modification by epidemiologic factors;Ahn;Cancer Epidemiol. Biomark. Prev.,2006

2. Candidate genes implicated in type 1 diabetes susceptibility;Aribi;Curr. Diabetes Rev.,2008

3. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review;Bag;Cancer Epidemiol. Biomark. Prev.,2008

4. Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus;Banerjee;Indian J. Hum. Genet.,2014

5. Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus;Barcala Tabarrozzi;Clin. Exp. Immunol.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Manganese Superoxide Dismutase and Human Diseases;International Journal of Molecular Sciences;2022-12-14

2. Endogenous Enzymatic Antioxidant Defense and Pathologies;Antioxidants - Benefits, Sources, Mechanisms of Action;2021-09-08

3. Polymorphism of MnSOD 47C/T antioxidant enzymes and type 1 diabetes;Diabetes;2020

4. Human Leukocyte Antigens (HLA) Genes Association in Type 1 Diabetic Nephropathy;Endocrine, Metabolic & Immune Disorders - Drug Targets;2019-11-11

5. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease;Journal of Neuroinflammation;2019-02-27